Mitchell Levy, MD, FCCM, discusses a perspectives article published in the October 19, 2006, issue of the New England Journal of Medicine, titled Surviving Sepsis-Practice Guidelines, Marketing Campaigns, and Eli Lilly, which criticizes the campaign and its major funding source, Eli Lilly.
